Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2004
02/05/2004CA2494040A1 Multi-step method for the differentiation of insulin positive, glucose
02/05/2004CA2493949A1 Modified small interfering rna molecules and methods of use
02/05/2004CA2493676A1 Methods for perfusion and plating of primary hepatocytes and a medium therefore
02/05/2004CA2493590A1 Auto-stimulating cells and method for making and using the same
02/05/2004CA2492542A1 Oligodendrocyte production from multipotent neural stem cells
02/05/2004CA2492500A1 Method for enhancing yield of recombinant protein production from plants
02/05/2004CA2492447A1 Taci antibodies and uses thereof
02/05/2004CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
02/05/2004CA2492332A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis
02/05/2004CA2492295A1 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
02/04/2004EP1386961A2 Modified reductase and its gene and use thereof
02/04/2004EP1386932A1 Improved humanized immunoglobulins
02/04/2004EP1386931A1 Human neurotrimin homologue
02/04/2004EP1386616A1 Antibordetella vaccine
02/04/2004EP1386612A1 Drugs fo rpromoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid
02/04/2004EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
02/04/2004EP1386004A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
02/04/2004EP1385995A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies
02/04/2004EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders
02/04/2004EP1385977A2 Secreted proteins
02/04/2004EP1385967A2 Non aggregating fluorescent proteins and methods for using the same
02/04/2004EP1385966A2 Recombinant fusion proteins and the trimers thereof
02/04/2004EP1385963A2 Polypeptides derived from rna polymerases and use thereof
02/04/2004EP1385960A2 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
02/04/2004EP1385959A2 Method of producing recombinant antibodies against tumours
02/04/2004EP1385958A2 Human tachykinin-related splice variants and compositions thereof
02/04/2004EP1385957A1 Functions for d52 and ra006 nucleic acids and polypeptides
02/04/2004EP1385955A2 Cell adhesion proteins
02/04/2004EP1385954A2 Proteins associated with cell growth, differentiation, and death
02/04/2004EP1385953A2 Proteins and nucleic acids encoding same
02/04/2004EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells
02/04/2004EP1385946A2 A system for inducible expression in eukaryotic cells
02/04/2004EP1385945A1 Novel mutation
02/04/2004EP1385943A2 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants
02/04/2004EP1385938A1 Method and culture medium for producing neural cells expressing tyrosine hydroxylase
02/04/2004EP1385936A2 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker
02/04/2004EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
02/04/2004EP1385934A2 Pufa polyketide synthase systems and uses thereof
02/04/2004EP1385933A1 Culture medium for cell growth and transfection
02/04/2004EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
02/04/2004EP1385883A2 Transmembrane proteins
02/04/2004EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
02/04/2004EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents
02/04/2004EP1385864A1 Vascular endothelial growth factor 2
02/04/2004EP1385862A2 Vascular endothelial growth factor 2
02/04/2004EP1385861A2 Compositions and methods relating to lung specific genes and proteins
02/04/2004EP1385559A1 Chitosan and hydroxy carboxylic acid based porous and non-porous matrices
02/04/2004EP1385544A2 Humanized antibodies
02/04/2004EP1385540A2 Composition and method for increasing cell density in cell cultures infected with lentivirus
02/04/2004EP1385538A2 Chimeric vaccines
02/04/2004EP1385533A1 Module of pd-1 interactions with its ligands
02/04/2004EP1385531A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
02/04/2004EP1385466A2 Oncolytic virus therapy
02/04/2004EP0938578B1 Genetic modification of primate hemopoietic repopulating stem cells
02/04/2004EP0925067B1 Graft from submucosal intestinal tissue for repairing neurological tissue
02/04/2004EP0906069B1 Tissue re-surfacing with hydrogel-cell compositions
02/04/2004EP0848755B9 Vegf-related protein
02/04/2004EP0842287B1 High efficiency helper system for aav vector production
02/04/2004EP0789766B1 Chimeric papillomavirus-like particles
02/04/2004EP0730404B1 Amphiphilic imidazolinium derivatives
02/04/2004EP0698094B1 Bmp-11 compositions
02/04/2004CN1473198A Genetic engineering of syringyl-enriched lignin in plants
02/04/2004CN1473195A Identification and characterization of anthocyanin mutant (ANT1) in tomato
02/04/2004CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
02/04/2004CN1472324A Encoding DNA sequence and amino sequence of sunflower gama tocopherol methyl transferases and use thereof
02/04/2004CN1472314A Immunity expression of AIDS virus O and its use
02/04/2004CN1472312A Production of artificial mammary male and female gametes and making them into artificial zygotes by separating/fusing bisexual somatic cells
02/04/2004CN1472311A Directed induction of converting animal fibroblast into epithelioid cell of mammary gland
02/04/2004CN1472222A DREB transcription factor of corn and its encoding genes and use
02/04/2004CN1137263C ATP sensitive potassium channel gene defective animal tissues and cells
02/03/2004US6686517 Healthy edible sprouts and turnips of the raphanus plants containing high levels of anthocyanins, free-radical scaengers; grown as purple sprouts of alfalfa-type or two-leafed plantlets; vegetables; nutriceuticals
02/03/2004US6686516 Expression of trehalose 6-phosphate synthase in plant plastids
02/03/2004US6686514 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking
02/03/2004US6686460 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
02/03/2004US6686452 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP
02/03/2004US6686449 Mutant presenilin 1 polypeptides
02/03/2004US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto
02/03/2004US6686342 Bicompatible poly-β-1→4-N-acetylglucosamine
02/03/2004US6686197 Method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
02/03/2004US6686177 Delayed onset of action
02/03/2004US6686153 PRV-1 gene and the use thereof
02/03/2004US6685957 Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
02/03/2004US6685941 Immuosuppressant
02/03/2004US6685936 Administering lymphocytes
02/03/2004US6685934 Neurodegenerative diseases.
02/03/2004US6685911 Sensitization process for antigen-presenting cells and means for implementing the process
02/03/2004CA2095735C Monoclonal antibodies to hepatitis c virus and method for using same
02/03/2004CA2025597C Vaccine against lyme disease
01/2004
01/29/2004WO2004009822A2 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses
01/29/2004WO2004009813A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE WITH THE USE OF PAPILOMAVIRUS VECTOR
01/29/2004WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
01/29/2004WO2004009801A1 Non-antigen presenting cells for selecting t cells
01/29/2004WO2004009799A2 Ion channel receptor and uses thereof
01/29/2004WO2004009782A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics
01/29/2004WO2004009780A2 Preventing ischemia-induced cell damage
01/29/2004WO2004009777A2 Compositions and methods to select dendritic cells from a heterogeneous cell population
01/29/2004WO2004009768A2 Viral vectors containing recombination sites
01/29/2004WO2004009767A2 Cell therapy for regeneration
01/29/2004WO2004009766A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
01/29/2004WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof